SCOPE FLUIDICS SA ZY-10 (S84) - Cash Flow Conversion Efficiency
Based on the latest financial reports, SCOPE FLUIDICS SA ZY-10 (S84) has a cash flow conversion efficiency ratio of -0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-11.68 Million ≈ $-13.65 Million USD) by net assets (€162.43 Million ≈ $189.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SCOPE FLUIDICS SA ZY-10 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how SCOPE FLUIDICS SA ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SCOPE FLUIDICS SA ZY-10 debt and liabilities for a breakdown of total debt and financial obligations.
SCOPE FLUIDICS SA ZY-10 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SCOPE FLUIDICS SA ZY-10 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Imaflex Inc
V:IFX
|
0.039x |
|
Cheer Time Enterprise Co Ltd
TW:3229
|
-0.031x |
|
PS Tec. Co. Ltd
KQ:002230
|
0.036x |
|
Max India Limited
NSE:MAXIND
|
-0.098x |
|
Highland Copper Company Inc.
V:HI
|
-0.087x |
|
Alcadon Group AB
ST:ALCA
|
0.063x |
|
Krystal Integrated Services Ltd
NSE:KRYSTAL
|
-0.026x |
|
Chainqui Construction Development Co Ltd
TW:2509
|
-0.121x |
Annual Cash Flow Conversion Efficiency for SCOPE FLUIDICS SA ZY-10 (2021–2025)
The table below shows the annual cash flow conversion efficiency of SCOPE FLUIDICS SA ZY-10 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see SCOPE FLUIDICS SA ZY-10 (S84) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €162.43 Million ≈ $189.90 Million |
€-46.11 Million ≈ $-53.91 Million |
-0.284x | -65.50% |
| 2024-12-31 | €146.35 Million ≈ $171.10 Million |
€-25.10 Million ≈ $-29.35 Million |
-0.172x | +27.15% |
| 2023-12-31 | €80.93 Million ≈ $94.62 Million |
€-19.06 Million ≈ $-22.28 Million |
-0.235x | -178.45% |
| 2022-12-31 | €332.97 Million ≈ $389.28 Million |
€-28.16 Million ≈ $-32.92 Million |
-0.085x | +97.33% |
| 2021-12-31 | €6.74 Million ≈ $7.88 Million |
€-21.37 Million ≈ $-24.98 Million |
-3.171x | -- |
About SCOPE FLUIDICS SA ZY-10
Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. The company offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is based in Warsaw, Poland.